164 related articles for article (PubMed ID: 8057449)
1. Induction in vitro of primary cytotoxic T-lymphocyte responses with DNA encoding herpes simplex virus proteins.
Rouse RJ; Nair SK; Lydy SL; Bowen JC; Rouse BT
J Virol; 1994 Sep; 68(9):5685-9. PubMed ID: 8057449
[TBL] [Abstract][Full Text] [Related]
2. Cellular interactions in the cytotoxic T lymphocyte response to herpes simplex virus antigens: differential antigen activation requirements for the helper T lymphocyte and cytotoxic T lymphocyte precursors.
Schmid DS; Rouse BT
J Immunol; 1983 Jul; 131(1):479-84. PubMed ID: 6223080
[TBL] [Abstract][Full Text] [Related]
3. Immunogenicity of herpes simplex virus type 1 mutants containing deletions in one or more alpha-genes: ICP4, ICP27, ICP22, and ICP0.
Brehm M; Samaniego LA; Bonneau RH; DeLuca NA; Tevethia SS
Virology; 1999 Apr; 256(2):258-69. PubMed ID: 10191191
[TBL] [Abstract][Full Text] [Related]
4. Induction and persistence of a cytotoxic T lymphocyte (CTL) response against a herpes simplex virus-specific CTL epitope expressed in a cellular protein.
Fu TM; Bonneau RH; Epler M; Tevethia MJ; Alam S; Verner K; Tevethia SS
Virology; 1996 Aug; 222(1):269-74. PubMed ID: 8806508
[TBL] [Abstract][Full Text] [Related]
5. Human CD8+ herpes simplex virus-specific cytotoxic T-lymphocyte clones recognize diverse virion protein antigens.
Tigges MA; Koelle D; Hartog K; Sekulovich RE; Corey L; Burke RL
J Virol; 1992 Mar; 66(3):1622-34. PubMed ID: 1310769
[TBL] [Abstract][Full Text] [Related]
6. Apparent requirement for CD4+ T cells in primary anti-herpes simplex virus cytotoxic T-lymphocyte induction can be overcome by optimal antigen presentation.
Mercadal CM; Martin S; Rouse BT
Viral Immunol; 1991; 4(3):177-86. PubMed ID: 1687350
[TBL] [Abstract][Full Text] [Related]
7. Protective immunity against herpes simplex virus (HSV) type 1 following oral administration of recombinant Salmonella typhimurium vaccine strains expressing HSV antigens.
Karem KL; Bowen J; Kuklin N; Rouse BT
J Gen Virol; 1997 Feb; 78 ( Pt 2)():427-34. PubMed ID: 9018066
[TBL] [Abstract][Full Text] [Related]
8. Induction of cytotoxic T lymphocytes by intramuscular immunization with plasmid DNA is facilitated by bone marrow-derived cells.
Doe B; Selby M; Barnett S; Baenziger J; Walker CM
Proc Natl Acad Sci U S A; 1996 Aug; 93(16):8578-83. PubMed ID: 8710913
[TBL] [Abstract][Full Text] [Related]
9. In vivo priming and activation of memory cytotoxic T-lymphocytes (CTL) by a chimeric simian virus 40 T antigen expressing an eight amino acid residue herpes simplex virus gB CTL epitope.
Bonneau RH; Fu TM; Tevethia SS
Virology; 1993 Dec; 197(2):782-7. PubMed ID: 7504370
[TBL] [Abstract][Full Text] [Related]
10. Immunization with a single major histocompatibility complex class I-restricted cytotoxic T-lymphocyte recognition epitope of herpes simplex virus type 2 confers protective immunity.
Blaney JE; Nobusawa E; Brehm MA; Bonneau RH; Mylin LM; Fu TM; Kawaoka Y; Tevethia SS
J Virol; 1998 Dec; 72(12):9567-74. PubMed ID: 9811690
[TBL] [Abstract][Full Text] [Related]
11. Cutting edge: conventional CD8 alpha+ dendritic cells are preferentially involved in CTL priming after footpad infection with herpes simplex virus-1.
Smith CM; Belz GT; Wilson NS; Villadangos JA; Shortman K; Carbone FR; Heath WR
J Immunol; 2003 May; 170(9):4437-40. PubMed ID: 12707318
[TBL] [Abstract][Full Text] [Related]
12. Th-cytotoxic T-lymphocyte chimeric epitopes extended by Nepsilon-palmitoyl lysines induce herpes simplex virus type 1-specific effector CD8+ Tc1 responses and protect against ocular infection.
Zhang X; Issagholian A; Berg EA; Fishman JB; Nesburn AB; BenMohamed L
J Virol; 2005 Dec; 79(24):15289-301. PubMed ID: 16306600
[TBL] [Abstract][Full Text] [Related]
13. Herpes simplex virus-specific human cytotoxic T-cell colonies expressing either gamma delta or alpha beta T-cell receptor: role of accessory molecules on HLA-unrestricted killing of virus-infected targets.
Maccario R; Comoli P; Percivalle E; Montagna D; Locatelli F; Gerna G
Immunology; 1995 May; 85(1):49-56. PubMed ID: 7635521
[TBL] [Abstract][Full Text] [Related]
14. High frequency of cross-reactive cytotoxic T lymphocytes elicited during the virus-induced polyclonal cytotoxic T lymphocyte response.
Nahill SR; Welsh RM
J Exp Med; 1993 Feb; 177(2):317-27. PubMed ID: 8093891
[TBL] [Abstract][Full Text] [Related]
15. Phenotypic identification of antigen-dependent and antigen-independent CD8 CTL precursors in the draining lymph node during acute cutaneous herpes simplex virus type 1 infection.
McNally JM; Dempsey D; Wolcott RM; Chervenak R; Jennings SR
J Immunol; 1999 Jul; 163(2):675-81. PubMed ID: 10395657
[TBL] [Abstract][Full Text] [Related]
16. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
J Virol; 2017 May; 91(9):. PubMed ID: 28228587
[TBL] [Abstract][Full Text] [Related]
17. Contribution of direct and cross-presentation to CTL immunity against herpes simplex virus 1.
Jirmo AC; Nagel CH; Bohnen C; Sodeik B; Behrens GM
J Immunol; 2009 Jan; 182(1):283-92. PubMed ID: 19109159
[TBL] [Abstract][Full Text] [Related]
18. Herpes simplex virus type 1-specific cytotoxic T lymphocytes recognize immediate-early protein ICP27.
Banks TA; Allen EM; Dasgupta S; Sandri-Goldin R; Rouse BT
J Virol; 1991 Jun; 65(6):3185-91. PubMed ID: 1709698
[TBL] [Abstract][Full Text] [Related]
19. DNA-mediated immunization to the hepatitis B surface antigen. Activation and entrainment of the immune response.
Whalen RG; Leclerc C; Dériaud E; Schirmbeck R; Reimann J; Davis HL
Ann N Y Acad Sci; 1995 Nov; 772():64-76. PubMed ID: 8546414
[TBL] [Abstract][Full Text] [Related]
20. Kinetics of primary and memory cytotoxic T lymphocyte responses to herpes simplex virus 1 infection: granzyme B mediated CTL activity.
Gorgian Mohammadi M; Bamdad T; Parsania M; Hashemi HR; Puyanfard S
Iran J Immunol; 2009 Mar; 6(1):22-7. PubMed ID: 19293474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
